{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-062952","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2023-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.919388+00:00","generated_at":"2026-06-18T09:47:49.172013+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Revolution Medicines closes public offering of 15.7M shares for $323.6M net proceeds","bullets":["Offering of 15,681,818 shares of common stock at $22.00 per share to the public.","Underwriters purchased at $20.68 per share; net proceeds of approx. $323.6M.","Full exercise of underwriters' option; 30-day option period for additional 2M shares.","Company and insiders subject to 60-day lock-up from prospectus date.","Lead underwriters: J.P. Morgan, Cowen, SVB Securities, Guggenheim Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-062952","json":"https://secwatch.observer/filing/0001193125-23-062952.json","markdown":"https://secwatch.observer/filing/0001193125-23-062952.md","text":"https://secwatch.observer/filing/0001193125-23-062952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523062952/0001193125-23-062952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523062952/d473040d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T09:47:49.172013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}